Levonorgestrel 52 mg intrauterine system

COMBINATION_PRODUCT2 trials

Sponsors

Medicines360, University of Utah

Conditions

ContraceptionMenorrhagia

Phase 3

Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding

CompletedNCT03642210

Medicines360Menorrhagia

Start: 2019-01-17End: 2021-10-12Updated: 2024-05-14

Phase 4

Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

RecruitingNCT05444582

University of UtahContraception

Start: 2022-11-07End: 2027-07-31Target: 1404Updated: 2026-04-16

Related Papers

Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device

Obstetrics and Gynecology2023-04-0514 citations